Inventor
PHAM SON MINH
US35 patents
⚠️ This page may combine multiple inventors who share the name “PHAM SON MINH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NUVATION BIO INC
18 patentsUS11292782B2Apr 5, 2022
Diarylhydantoin compounds and methods of use thereof
NUVATION BIO INC6 citations73
US11826430B2Nov 28, 2023
Anti-cancer nuclear hormone receptor-targeting compounds
NUVATION BIO INC2 citations71
US11584756B2Feb 21, 2023
Heterocyclic compounds as BET inhibitors
NUVATION BIO INC3 citations71
US11034669B2Jun 15, 2021
Pyrrole and pyrazole compounds and methods of use thereof
NUVATION BIO INC6 citations71
US12006314B2Jun 11, 2024
Anti-cancer nuclear hormone receptor-targeting compounds
NUVATION BIO INC2 citations70
US11834458B2Dec 5, 2023
Anti-cancer nuclear hormone receptor-targeting compounds
NUVATION BIO INC2 citations70
US10807994B2Oct 20, 2020
Heterocyclic compounds and uses thereof
NUVATION BIO INC3 citations68
US10793561B2Oct 6, 2020
1,8-naphthyridinone compounds and uses thereof
NUVATION BIO INC3 citations68
US12208141B2Jan 28, 2025
Anti-cancer nuclear hormone receptor-targeting compounds
NUVATION BIO INC0 citations61
US11952349B2Apr 9, 2024
Anti-cancer nuclear hormone receptor-targeting compounds
NUVATION BIO INC2 citations59
US11299493B2Apr 12, 2022
Heterocyclic compounds and uses thereof
NUVATION BIO INC0 citations58
US11028058B2Jun 8, 2021
Heterocyclic compounds as adenosine antagonists
NUVATION BIO INC2 citations58
US11174252B2Nov 16, 2021
Heterocyclic compounds as kinase inhibitors
NUVATION BIO INC1 citations57
US11306071B2Apr 19, 2022
Heterocyclic compounds as adenosine antagonists
NUVATION BIO INC0 citations56
US12398121B2Aug 26, 2025
Anti-cancer nuclear hormone receptor-targeting compounds
NUVATION BIO INC0 citations50
US11192900B2Dec 7, 2021
Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors
NUVATION BIO INC0 citations50
US11332473B2May 17, 2022
Substituted pyrazolo[3,4-d]pyrimidines as Wee1 inhibitors
NUVATION BIO INC0 citations46
US11254670B2Feb 22, 2022
1,8-naphthyridinone compounds and uses thereof
NUVATION BIO INC0 citations46
VERSEON CORP
9 patentsUS9533970B2Jan 3, 2017
Multisubstituted aromatic compounds as serine protease inhibitors
VERSEON CORP5 citations81
US9533967B2Jan 3, 2017
Multisubstituted aromatic compounds as inhibitors of thrombin
VERSEON CORP5 citations81
US10189810B2Jan 29, 2019
Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
VERSEON CORP3 citations70
US9963440B2May 8, 2018
Multisubstituted aromatic compounds as inhibitors of thrombin
VERSEON CORP3 citations70
US9687479B2Jun 27, 2017
Multisubstituted aromatic compounds as serine protease inhibitors
VERSEON CORP2 citations70
US10653674B2May 19, 2020
Multisubstituted aromatic compounds as inhibitors of thrombin
VERSEON CORP1 citations60
US10251872B2Apr 9, 2019
Multisubstituted aromatic compounds as serine protease inhibitors
VERSEON CORP0 citations49
US10058541B2Aug 28, 2018
Multisubstituted aromatic compounds as serine protease inhibitors
VERSEON CORP0 citations49
US9951025B2Apr 24, 2018
Halogenopyrazoles as inhibitors of thrombin
VERSEON CORP0 citations39
MEDIVATION TECH LLC
5 patentsUS10030004B2Jul 24, 2018
Compounds and methods of use
MEDIVATION TECH LLC6 citations81
US11702401B2Jul 18, 2023
Compounds and methods of use
MEDIVATION TECH LLC0 citations60
US11053216B2Jul 6, 2021
Compounds and methods of use
MEDIVATION TECH LLC0 citations60
US10501436B2Dec 10, 2019
Compounds and methods of use
MEDIVATION TECH LLC0 citations49
US10189826B2Jan 29, 2019
Heterocyclic compounds and methods of use
MEDIVATION TECH LLC0 citations32